Ledger.Open graph →
SEC Form D · filed July 15, 2019

Bolt Biotherapeutics, Inc

Offering
$40.1M
Sold
$40.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
REDWOOD CITY, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Charles L. Adelmann, M.D · Bridgeport, CTExec · DirectorMir Joffrey · DALLAS, TXDirectorWeaver H. Gaines · Newberry, FLExecDante Andrade · Dallas, TXDirectorAshish G. Khanna · Redwood City, CADirectorScott Graves · Los Angeles, CAExec · DirectorBryan H. Anderson · Phoenix, AZExecKirk H. Howell · Phoenix, AZDirectorMaximiliano H. Palacio · Phoenix, AZDirectorAshish G. Khanna · Redwood City, CADirectorRichard Miller · BOYNTON BEACH, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗